- CohBar Inc And Morphogenesis Inc To Discuss Definitive Merger Agreement Call TranscriptMay 23, 2023
- Q3 2022 CohBar Inc Earnings Call TranscriptNov 08, 2022$2.27 (+2.25%)Earnings
- Q2 2022 CohBar Inc Earnings Call TranscriptAug 15, 2022$5.67 (-0.58%)Earnings
- Q1 2022 CohBar Inc Earnings Call TranscriptMay 16, 2022$5.96 (-3.17%)Earnings
- Q4 2021 CohBar Inc Earnings Call TranscriptMar 29, 2022$9.67 (+4.37%)Earnings
- Q3 2021 CohBar Inc Earnings Call TranscriptNov 15, 2021$19.8 (-5.32%)Earnings
- CohBar Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q2 2021 CohBar Inc Earnings Call TranscriptAug 10, 2021$38.7Earnings
- Q1 2021 CohBar Inc Earnings Call TranscriptMay 17, 2021$36.6 (+1.67%)Earnings
- Q4 2020 CohBar Inc Earnings Call TranscriptMar 30, 2021$37.8 (-4.55%)Earnings
- Q3 2020 CohBar Inc Earnings Call TranscriptNov 16, 2020$34.5 (+5.50%)Earnings
- CohBar, Inc. - Special Call TranscriptNov 06, 2020
- Q2 2020 CohBar Inc Earnings Call TranscriptAug 13, 2020$45.6 (-1.94%)Earnings
- CohBar, Inc. - Special Call TranscriptJun 16, 2020
- CohBar Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Q1 2020 CohBar Inc Earnings Call TranscriptMay 14, 2020$71.4 (-12.50%)Earnings
- Q4 2019 CohBar Inc Earnings Call TranscriptMar 12, 2020$43.8 (-17.05%)Earnings
- Q3 2019 CohBar Inc Earnings Call TranscriptNov 06, 2019$57 (-7.77%)Earnings
- Q2 2019 CohBar Inc Earnings Call TranscriptAug 07, 2019$42.6 (-0.70%)Earnings
- CohBar, Inc. Investor Update TranscriptJun 18, 2019
- CohBar Inc Annual Shareholders Meeting TranscriptJun 18, 2019
- Q1 2019 CohBar Inc Earnings Call TranscriptMay 07, 2019$84.3 (+2.93%)Earnings
- CohBar, Inc. - Special Call TranscriptMay 02, 2019
- Q4 2018 CohBar Inc Earnings Call TranscriptMar 18, 2019Earnings
CohBar, Inc. - Special Call Transcript
Good afternoon. My name is Matt, and I will be your conference operator today. At this time, I'd like to welcome everyone to the KOL Call on Mitochondria, a Source for Novel Therapeutics, hosted by CohBar, Inc. (Operator Instructions) Now I'd like to turn the call over to Philippe Calais, CohBar's Interim Chief Executive Officer.
Thank you, Matt, and welcome, everyone, to our conference call this morning featuring presentations by world-leading experts in the biology of aging, mitochondria and mitochondrial-derived peptides, which have the potential to be a new class of therapeutics targeting age-related diseases with underlying metabolic dysfunction.
We have an exciting agenda, and I believe this call will be very informative. We appreciate you joining us today.
Before we begin, we would like to call your attention to the fact that we will be making forward-looking statements during today's call, and we refer you to Slide #2 of our presentation, which you can see right now, for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)